Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma

Katsuhiro Uzawa(Chiba University), Hideki Tanzawa(Chiba University Hospital)

Scientific Reports

August 21, 2019

10.1038/s41598-019-48717-w

Cited by 39

Related Papers

Kinesin Family member 4A: A Potential Predictor for Progression of Human Oral Cancer

|PLoS ONE|2013|107

ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer

|Cancer Medicine|2015|76

Overexpression of CDCA2 in Human Squamous Cell Carcinoma: Correlation with Prevention of G1 Phase Arrest and Apoptosis

|PLoS ONE|2013|69

WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice

|Oncoscience|2014|58

Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis

|PLoS ONE|2015|56